Walgreens, AllianceRx Walgreens Pharmacy Study of Non-Infused Biologics in Rheumatoid Arthritis Treatment Underscores Importance of Medication Adherence
- S&P 500 and Nasdaq notch highest closes since early 2022
- U.S. economy adds 199,000 jobs in November
- Fed should 'lowball' rate cuts expectations next week says analyst after strong jobs data
- Bernstein's best idea for 2024? Short Tesla stock
- Analysts defend Broadcom as annual guidance falls short after FQ4 earnings beat
Retrospective cohort study compared adherence, healthcare cost and utilization.
Rheumatoid arthritis is an autoimmune and inflammatory disease, in which the immune system attacks healthy cells in the body by mistake, causing inflammation (painful swelling) most commonly in the joints of the hands, wrists and knees. In affected joint tissue, the lining of the joint becomes inflamed, causing damage which can lead to chronic pain or deformity.
The Pharmacy Quality Alliance (PQA) promotes a useful reporting metric of proportion of days covered (PDC) for non-infused biologic medications to treat RA. This metric is known as PDC-RA. The objective of the study was to identify significant associations between this PQA PDC adherence metric and total medical cost, hospitalizations, and LOS for RA patients.
For the study, researchers used both the MarketScan Commercial Claims and Encounters databases, and Supplemental or Coordination of Benefits databases from 2019 - 2020. They examined three types of yearly outcomes derived per patient: summed healthcare costs; any hospitalization within the year; and summed LOS per hospitalization event.
"Identifying barriers to adherence and educating patients on the importance of taking their medication can increase the patient's chance at disease improvement," says
About AllianceRx Walgreens Pharmacy
AllianceRx Walgreens Pharmacy (AllianceRxWP.com) provides hope and care for better tomorrows to patients with rare diseases and chronic conditions by delivering medications from its specialty and home delivery pharmacies. Our advanced analytical capabilities, pharmacy expertise and technology solutions enable providers, pharmaceutical manufacturers, and health plans to deliver optimal health outcomes. Through personalized care and clinical programs, along with access to the leading number of limited distribution drugs, patients can get back to what matters most. A subsidiary of Walgreen Co., the company holds several national pharmacy accreditations and has team members across
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA's purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America,
Manager, pharmacy communications
View original content to download multimedia:https://www.prnewswire.com/news-releases/walgreens-alliancerx-walgreens-pharmacy-study-of-non-infused-biologics-in-rheumatoid-arthritis-treatment-underscores-importance-of-medication-adherence-301931160.html
SOURCE AllianceRx Walgreens Pharmacy
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SUSTAINABLE MARKETS INITIATIVE AGRIBUSINESS TASK FORCE LAUNCHES BLENDED FINANCE FRAMEWORK TO MAKE REGENERATIVE FARMING MAINSTREAM
- Walgreens Boots Alliance (WBA) call put ratio 2.7 calls to 1 put as share price up 7.6%
- AYA Platform of Enjinstarter Granted Virtual Asset Service Provider Licence by Dubai’s Virtual Assets Regulatory Authority
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!